Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03402139

Early Childhood Obesity Programming by Intrauterine Growth Restriction

Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Montefiore Medical Center · Academic / Other
Sex
All
Age
1 Hour – 24 Months
Healthy volunteers
Accepted

Summary

The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life.

Detailed description

Epidemiological studies of multiple cohorts suggest an increased risk for obesity, cardiovascular disease-related death and type 2 diabetes in low birth weight infants. However, the molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Alterations in DNA methylation during fetal life have been proposed to be one of the mechanisms that regulate this phenotype. Here, the investigators address major questions about early childhood obesity programming by studying purified subpopulations of CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life. The investigators will correlate altered CD3+ T-cell DNA methylation profiles in cord and peripheral blood samples and functional changes in CD3+ T-cells with adiposity in childhood.

Conditions

Timeline

Start date
2018-09-01
Primary completion
2028-03-01
Completion
2028-03-01
First posted
2018-01-18
Last updated
2025-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03402139. Inclusion in this directory is not an endorsement.